Chin‐Cheng Su

605 total citations
21 papers, 508 citations indexed

About

Chin‐Cheng Su is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Chin‐Cheng Su has authored 21 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Complementary and alternative medicine and 8 papers in Pharmacology. Recurrent topics in Chin‐Cheng Su's work include Traditional Chinese Medicine Analysis (10 papers), Medicinal Plant Pharmacodynamics Research (7 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Chin‐Cheng Su is often cited by papers focused on Traditional Chinese Medicine Analysis (10 papers), Medicinal Plant Pharmacodynamics Research (7 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Chin‐Cheng Su collaborates with scholars based in Taiwan. Chin‐Cheng Su's co-authors include Tsung‐Lang Chiu, Jung‐Cheng Kang, Guangwei Chen, Ming‐Huan Chan, Dar‐Ren Chen, Shou‐Jen Kuo, Su‐Yu Chien, Chun‐Yuan Cheng, Jai‐Sing Yang and Jing‐Gung Chung and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, American Journal of Physiology-Endocrinology and Metabolism and Phytotherapy Research.

In The Last Decade

Chin‐Cheng Su

21 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chin‐Cheng Su Taiwan 14 302 183 100 81 78 21 508
Kaikai Shen China 15 320 1.1× 108 0.6× 76 0.8× 91 1.1× 86 1.1× 18 520
Li-Mien Chen Taiwan 17 328 1.1× 101 0.6× 55 0.6× 74 0.9× 117 1.5× 22 685
Mianhua Wu China 14 436 1.4× 66 0.4× 71 0.7× 99 1.2× 172 2.2× 55 680
Jiajun Liu China 14 412 1.4× 91 0.5× 61 0.6× 49 0.6× 153 2.0× 25 520
Aruljothi Subramaniam United States 7 367 1.2× 97 0.5× 63 0.6× 205 2.5× 111 1.4× 8 653
Ji‐Yao Chou Hong Kong 13 213 0.7× 59 0.3× 68 0.7× 74 0.9× 49 0.6× 19 416
Tai‐Ping D. Fan United Kingdom 7 490 1.6× 71 0.4× 90 0.9× 63 0.8× 122 1.6× 8 663
Heran Wang China 11 388 1.3× 84 0.5× 55 0.6× 187 2.3× 179 2.3× 24 686
Xianjun Yu China 14 286 0.9× 98 0.5× 25 0.3× 57 0.7× 50 0.6× 20 454

Countries citing papers authored by Chin‐Cheng Su

Since Specialization
Citations

This map shows the geographic impact of Chin‐Cheng Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chin‐Cheng Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chin‐Cheng Su more than expected).

Fields of papers citing papers by Chin‐Cheng Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chin‐Cheng Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chin‐Cheng Su. The network helps show where Chin‐Cheng Su may publish in the future.

Co-authorship network of co-authors of Chin‐Cheng Su

This figure shows the co-authorship network connecting the top 25 collaborators of Chin‐Cheng Su. A scholar is included among the top collaborators of Chin‐Cheng Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chin‐Cheng Su. Chin‐Cheng Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Chin‐Cheng. (2018). Tanshinone IIA inhibits gastric carcinoma AGS cells by decreasing the protein expression of VEGFR and blocking Ras/Raf/MEK/ERK pathway. International Journal of Molecular Medicine. 41(4). 2389–2396. 28 indexed citations
2.
3.
Su, Chin‐Cheng & Tsung‐Lang Chiu. (2016). Tanshinone IIA decreases the protein expression of EGFR, and IGFR blocking the PI3K/Akt/mTOR pathway in gastric carcinoma AGS cells both in vitro and in vivo. Oncology Reports. 36(2). 1173–1179. 39 indexed citations
4.
Su, Chin‐Cheng. (2015). Tanshinone IIA Could Inhibit Pancreatic Cancer BxPC-3 Cells through Increasing PERK, ATF6, Caspase-12 and CHOP Expression to Induce Apoptosis. Journal of Biomedical Science and Engineering. 8(3). 149–159. 7 indexed citations
5.
Su, Chin‐Cheng, Chih‐Jung Chen, Shou‐Jen Kuo, & Dar‐Ren Chen. (2015). Myoid hamartoma of the breast with focal chondromyoxid metaplasia and pseudoangiomatous stromal hyperplasia: A case report. Oncology Letters. 9(4). 1787–1789. 4 indexed citations
6.
7.
Su, Chin‐Cheng. (2014). Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.. PubMed. 34(12). 7097–110. 38 indexed citations
8.
Chen, Yao‐Li, Su‐Yu Chien, Shou‐Jen Kuo, et al.. (2013). Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro. Molecular Medicine Reports. 7(5). 1487–1493. 12 indexed citations
9.
10.
Chien, Su‐Yu, Shou‐Jen Kuo, Dar‐Ren Chen, & Chin‐Cheng Su. (2013). Sann-Joong-Kuey-Jian-Tang decreases the protein expression of Mcl-1 and TCTP and increases that of TNF-α and Bax in BxPC-3 pancreatic carcinoma cells. International Journal of Molecular Medicine. 32(1). 85–92. 5 indexed citations
11.
Chiu, Tsung‐Lang, et al.. (2012). The treatment of glioblastoma multiforme through activation of microglia and TRAIL induced by rAAV2-mediated IL-12 in a syngeneic rat model. Journal of Biomedical Science. 19(1). 45–45. 34 indexed citations
12.
Su, Chin‐Cheng, Su‐Yu Chien, Shou‐Jen Kuo, et al.. (2012). Tanshinone IIA inhibits human breast cancer MDA-MB-231 cells by decreasing LC3-II, Erb-B2 and NF-κBp65. Molecular Medicine Reports. 5(4). 1019–1022. 28 indexed citations
13.
Su, Chin‐Cheng. (2011). Tanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of P-gp and LC3-II. Experimental and Therapeutic Medicine. 3(3). 555–559. 42 indexed citations
14.
Lai, Hung‐Wen, Chin‐Cheng Su, Shou‐Jen Kuo, et al.. (2011). Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study. Evidence-based Complementary and Alternative Medicine. 2011(1). 841564–841564. 14 indexed citations
15.
16.
Su, Chin‐Cheng, Jai‐Sing Yang, Chi‐Cheng Lu, et al.. (2010). Curcumin inhibits human lung large cell carcinoma cancer tumour growth in a murine xenograft model. Phytotherapy Research. 24(2). 189–192. 30 indexed citations
17.
Su, Chin‐Cheng, Guangwei Chen, Jung‐Cheng Kang, & Ming‐Huan Chan. (2008). Growth Inhibition and Apoptosis Induction by Tanshinone IIA in Human Colon Adenocarcinoma Cells. Planta Medica. 74(11). 1357–1362. 46 indexed citations
18.
Jao, Shu‐Wen, et al.. (2007). Stapled Hemorrhoidectomy versus Conventional Excision Hemorrhoidectomy for Acute Hemorrhoidal Crisis. Journal of Gastrointestinal Surgery. 11(12). 1654–1661. 13 indexed citations
19.
Lin, Jing‐Pin, Jai‐Sing Yang, Tsan‐Hung Chiu, et al.. (2007). GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells.. PubMed. 27(5A). 3379–86. 46 indexed citations
20.
Su, Chin‐Cheng, et al.. (1992). Selective reduction of creatine kinase subunit mRNAs in striated muscle of diabetic rats. American Journal of Physiology-Endocrinology and Metabolism. 263(2). E310–E316. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaikai Shen Breakdown of academic impact, for papers by Li-Mien Chen Breakdown of academic impact, for papers by Mianhua Wu Breakdown of academic impact, for papers by Jiajun Liu Breakdown of academic impact, for papers by Aruljothi Subramaniam Breakdown of academic impact, for papers by Ji‐Yao Chou Breakdown of academic impact, for papers by Tai‐Ping D. Fan Breakdown of academic impact, for papers by Heran Wang Breakdown of academic impact, for papers by Xianjun Yu
Rankless by CCL
2026